Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

Newsroom
January 31st, 2011

Cook Pharmica Adds E. Morrey Atkinson, Ph.D., to Leadership Team as Vice President of Research and Development, Chief Scientific Officer


Bloomington, Ind. – E. Morrey Atkinson, Ph.D., has joined Cook Pharmica as vice president of research and development and chief scientific officer, company officials announced recently. Atkinson will be responsible for guiding the scientific direction of Cook Pharmica, relying on his extensive past experience with process development of gene therapies, vaccines, recombinant proteins and monoclonal antibodies.

“Morrey comes to us with a broad background of scientific and business experience in both the domestic and international marketplace,” said Tedd Green, president of Cook Pharmica. “His broad technical, management and leadership experience will be a great strength to our team and we are proud to welcome him to the Cook organization.”

Atkinson has almost two decades of experience in biologics development and has held various leadership positions in biotechnology manufacturing and development. Most recently, he was head of biotechnology manufacturing sciences and technology for Eli Lilly and Company in Kinsale, Ireland.

“I look forward to contributing my experience with biologics development to this organization,” Atkinson said. “With the potential to offer the broadest range of development and production services in the industry, Cook Pharmica has a bright future ahead, and I am excited to join this leadership team.”

Atkinson, who grew up in Indiana and Florida, graduated from Indiana University with a bachelor of science in biology and received his doctorate in biological sciences from Stanford University.

About Cook Pharmica
Cook Pharmica is a biopharmaceutical contract development and manufacturing organization (CDMO) with process development, clinical and commercial bulk drug substance manufacturing, formulation development, clinical and commercial parenteral drug product manufacturing, including liquid and lyophilized vials, prefilled syringes and secondary packaging, and an array of support services all at a single facility in Bloomington, IN. Founded in 2004, Cook Pharmica is a division of Cook Medical, the world’s largest privately held medical manufacturing company.

About Cook Medical
Founded in 1963, Cook Medical pioneered many of the medical devices now commonly used to perform minimally invasive medical procedures throughout the body. Today, the company integrates medical devices, drugs and biologic grafts to enhance patient safety and improve clinical outcomes. Since its inception, Cook has operated as a family-held private corporation. For more information, visit www.cookmedical.com. Follow Cook Medical on Twitter @CookMedicalPR.